Which antibiotics are appropriate for moderate non-purulent cellulitis?

Which antibiotics are appropriate for moderate non-purulent cellulitis?

• A. Ciprofloxacin
• B. Amoxicillin
• C. Penicillin, cefazolin, ceftriaxone, or clindamycin
• D. Vancomycin for all cases

Answer: (C)

Moderate non-purulent cellulitis is usually caused by beta-hemolytic streptococci and MSSA, so the antibiotics chosen should reliably cover these organisms while avoiding unnecessary MRSA coverage unless there are purulent features or specific risk factors. Penicillin targets streptococci effectively, while cefazolin and ceftriaxone provide broader Gram-positive coverage that includes MSSA, making them suitable for either oral or IV therapy depending on severity. Clindamycin also covers both streptococci and MSSA and is a good option for patients who cannot take beta-lactams. This combination of agents aligns with the typical microbiology of non-purulent cellulitis and the usual treatment approach for moderate disease. Vancomycin is reserved for scenarios where MRSA coverage is clearly needed or for more severe illness, which is not the standard approach for moderate non-purulent cellulitis. Ciprofloxacin has limited reliable activity against streptococci and is not preferred for cellulitis, and amoxicillin alone may not adequately cover MSSA.

Moderate non-purulent cellulitis is usually caused by beta-hemolytic streptococci and MSSA, so the antibiotics chosen should reliably cover these organisms while avoiding unnecessary MRSA coverage unless there are purulent features or specific risk factors. Penicillin targets streptococci effectively, while cefazolin and ceftriaxone provide broader Gram-positive coverage that includes MSSA, making them suitable for either oral or IV therapy depending on severity. Clindamycin also covers both streptococci and MSSA and is a good option for patients who cannot take beta-lactams. This combination of agents aligns with the typical microbiology of non-purulent cellulitis and the usual treatment approach for moderate disease.

Vancomycin is reserved for scenarios where MRSA coverage is clearly needed or for more severe illness, which is not the standard approach for moderate non-purulent cellulitis. Ciprofloxacin has limited reliable activity against streptococci and is not preferred for cellulitis, and amoxicillin alone may not adequately cover MSSA.